|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/16 | |
| A61P 7/02 |
| (11) | Number of the document | 1696940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04804944.9 |
| Date of filing the European patent application | 2004-12-20 | |
| (97) | Date of publication of the European application | 2006-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2007-03-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2004/053608 |
| Date | 2004-12-20 |
| (87) | Number | WO 2005/058334 |
| Date | 2005-06-30 |
| (30) | Number | Date | Country code |
| 03029359 | 2003-12-19 | EP |
| (72) |
HEGER, Andrea, AT
RÖMISCH, Jürgen, AT
SVAE, Tor-Einar, AT
MARGUERRE, Wolfgang, DE
|
| (73) |
Octapharma AG,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | A UNIVERSALLY APPLICABLE VIRUS INACTIVATED BLOOD PLASMA PRODUCED FROM PORTIONS OF NON-CAUCASIAN PLASMA |
| A UNIVERSALLY APPLICABLE VIRUS INACTIVATED BLOOD PLASMA PRODUCED FROM PORTIONS OF NON-CAUCASIAN PLASMA |